Is Your Insurance Policy Ready for the New EU Product Liability Directive?

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Is your insurance policy ready for the biggest shake-up in EU product liability in 40 years?

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

A major shift is coming for manufacturers, distributors, and suppliers across the EU. The new Directive (EU) 2024/2853 on Product Liability, effective from 9 December 2026, replaces a 40-year-old framework — and it fundamentally changes who can be held liable and what damages can be claimed.

What’s changing?

  • Broader definition of “product” – software, digital files, and even updates are now included.
  • Expanded damages – claims can cover psychological harm and data loss, not just physical damage.
  • Wider liability chain – not only manufacturers, but also authorised reps, importers, logistics providers, and in some cases distributors may face liability.
  • Strict liability principle remains – no proof of negligence is needed for claims to succeed.

Why it matters for your business

This expanded liability framework means your insurance coverage may no longer be sufficient. Policies need to be reviewed and adapted to cover:

  • Software and digital components
  • Psychological harm and data loss
  • Circular economy activities (repairs, remanufacturing, reuse)
  • Cybersecurity vulnerabilities in connected devices

The Directive also ties closely with MDR/IVDR obligations, raising the stakes for compliance and risk management.

Take action now

The countdown to 2026 has begun. Businesses across the medtech and life sciences sector need to reassess their risk exposure and ensure their insurance truly protects them under the new rules.

👉 Our full white paper explores the Directive in detail and provides practical steps to get your insurance policy ready.

Download the White Paper below

directive on product liability image landing page

View our other resources and company news

mock inspection blog header Case Study

Full GMP Internal Audit Program Executed On Time

A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

From local to global: scaling your QMS for UK–EU operations

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan QMS

Scale Your Quality System from UK to EU Without Losing Control

Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
SAP PALEX CSV Case Study Header Image (1500 x 844 px) Article

Pharmaceutical Equipment Qualification & Control System Validation

Qualifying process equipment and control systems is fundamental to GMP compliance. This guide breaks down how to define user requirements, apply risk-based testing, and maintain ...
Read More
mock inspection blog header Case Study

GMP Consultancy for a New Cannabis Manufacturing Plant

A start up cannabis manufacturer partnered with Rephine to design a GMP compliant facility, implement a practical Quality Management System and prepare for EU GMP ...
Read More
QMS IMP Header image case study May 25 Article

How an Internal Services Audit Can Maximise Your Regulatory Compliance

Internal services audits play a critical role in maintaining GMP compliance and driving continuous improvement. This article explores how structured gap assessments, internal audits and ...
Read More
GMP Raising the bar Blog series Header image May 25 Article

Effective QMS Management Post-Go-Live: Strategies for Governance, Releases, and Continuous Improvement

After QMS go live, compliance and performance depend on strong governance, structured release management and continuous improvement. Learn how to sustain control, adoption and long ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

GMP Consultancy for a New Manufacturing Plant

With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Article

Why Quality Can No Longer Live in Silos

Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards